Findings

What do systematic reviews say?

3 questions · 3 findings · 3 reviews · Childhood Cancer

No studies found 2 · 66.7%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 33.3%Moderate 0 · 0%High 0 · 0%

Treatment‐related mortality · patients with high‐risk neuroblastoma

Rapid COJEC showed no clear difference in treatment‐related mortality compared with standard induction therapies (low certainty).

1 finding from 1 review

Rapid COJEC versus standard induction therapies for high‐risk neuroblastoma 2015 · Cochrane Headline outcomes only
RR 1.21 [0.33, 4.39]
1 study · 234 participants
Low

Treatment‐related mortality ‐ not reported · People with high‐risk neuroblastoma pre‐treated with autologous haematopoietic stem cell transplantation

The review found no eligible studies for this question.

1 finding from 1 review

Treatment‐related mortality ‐ not reported · high‐risk neuroblastoma patients treated with autologous HSCT

The review found no eligible studies for this question.

1 finding from 1 review